Go Pro
NYSE:CAH

Cardinal Health (CAH) Stock Price, News & Analysis

Cardinal Health logo
$234.54 -1.48 (-0.63%)
Closing price 09/11/2026 03:58 PM Eastern
Extended Trading
$234.53 -0.01 (0.00%)
As of 09/11/2026 07:48 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

About Cardinal Health Stock (NYSE:CAH)

Advanced

Key Stats

Today's Range
$232.60
$239.43
50-Day Range
$221.09
$248.88
52-Week Range
$145.87
$258.30
Volume
1.11 million shs
Average Volume
1.39 million shs
Market Capitalization
$54.55 billion
P/E Ratio
32.44
Dividend Yield
0.88%
Price Target
$266.56
Consensus Rating
Moderate Buy

Company Overview

Cardinal Health, Inc. is a healthcare services and products company that supports the pharmaceutical and medical industries. Its Pharmaceutical and Specialty Solutions segment distributes branded, generic and specialty pharmaceuticals, over-the-counter products and consumer health items to pharmacies, hospitals, health systems and other healthcare providers. The segment also provides specialty pharmaceutical services, nuclear and radiopharmaceutical products, and related support for manufacturers and providers.

Through its Global Medical Products and Distribution segment, Cardinal Health manufactures, sources and distributes medical and surgical products, including gloves, gowns, syringes, exam-room supplies and other essential equipment. The company also provides supply chain management, inventory, logistics and other services to hospitals, ambulatory surgery centers, physician offices, clinical laboratories and other healthcare organizations. Its at-Home Solutions business supplies products and services for people managing medical conditions outside traditional care settings.

Founded in 1971 and headquartered in Dublin, Ohio, Cardinal Health primarily serves customers in the United States while supporting healthcare supply chains in select international markets. The company is led by Jason M. Hollar, who became chief executive officer in 2022.

AI Generated. May Contain Errors.

Cardinal Health Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
92nd Percentile Overall Score

CAH MarketRank™: 

Cardinal Health scored higher than 92% of companies evaluated by MarketBeat, and ranked 28th out of 904 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Cardinal Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.84, and is based on no strong buy ratings, 16 buy ratings, 3 hold ratings, and no sell ratings.

  • Upside Potential

    Cardinal Health has a consensus price target of $266.56, representing about 13.7% upside from its current price of $234.54.

  • Amount of Analyst Coverage

    Cardinal Health has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

  • Read more about Cardinal Health's stock forecast and price target.
  • Earnings Growth

    Earnings for Cardinal Health are expected to grow by 10.84% in the coming year, from $12.55 to $13.91 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Cardinal Health is 32.44, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 39.11.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Cardinal Health is 32.44, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 272.98.

  • Price to Earnings Growth Ratio

    Cardinal Health has a PEG Ratio of 1.42. PEG Ratios above 1 indicate that a company could be overvalued.

  • Read more about Cardinal Health's valuation and earnings.
  • Percentage of Shares Shorted

    2.89% of the float of Cardinal Health has been sold short.
  • Short Interest Ratio / Days to Cover

    Cardinal Health has a short interest ratio ("days to cover") of 4.44.
  • Change versus previous month

    Short interest in Cardinal Health has recently increased by 5.01%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Cardinal Health has a dividend yield of 0.87%, which is in the bottom 25% of all stocks that pay dividends.

  • Dividend Growth

    Cardinal Health has been increasing its dividend for 29 years.

  • Dividend Coverage

    The dividend payout ratio of Cardinal Health is 28.49%. This payout ratio is at a healthy, sustainable level, below 75%.

  • Dividend Sustainability

    Based on earnings estimates, Cardinal Health will have a dividend payout ratio of 14.81% next year. This indicates that Cardinal Health will be able to sustain or increase its dividend.

  • Read more about Cardinal Health's dividend.
  • News Sentiment

    Cardinal Health has a news sentiment score of 1.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.86 average news sentiment score of Healthcare companies.
  • News Coverage This Week

    MarketBeat has tracked 13 news articles for Cardinal Health this week, compared to 8 articles on an average week.
  • Search Interest

    Only 10 people have searched for CAH on MarketBeat in the last 30 days. This is a decrease of -47% compared to the previous 30 days.
  • MarketBeat Follows

    31 people have added Cardinal Health to their MarketBeat watchlist in the last 30 days. This is an increase of 520% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Cardinal Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $49,626,657.00 in company stock.

  • Percentage Held by Insiders

    0.12% of the stock of Cardinal Health is held by insiders.

  • Percentage Held by Institutions

    87.17% of the stock of Cardinal Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Cardinal Health's insider trading history.
Receive CAH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cardinal Health and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CAH Stock News Headlines

CAH Gains More Than 29% in 4 Months: Will the Uptrend Continue?
The retirement stock I'd buy before Nvidia today
In 2014, Marc Chaikin pointed readers toward Nvidia. Now the 60-year Wall Street veteran and creator of the Chaikin Money Flow indicator has a new top retirement pick. The company holds three fast-growing businesses -- including an autonomous vehicle unit and a streaming service with 10x Netflix's reach -- any of which could be spun off in the next 12 to 24 months. It also pays a dividend, a rarity among high-growth AI names. Chaikin lays out the full case in a new free presentation, no email or credit card required.tc pixel
Cardinal Health branded boxes on pallets sit amid automated conveyor systems in a distribution warehouse.
Cardinal Health Earnings: Can Perfection Get Priced In Twice?
Cardinal Health stock hit a new all-time high after mixed earnings, with analyst price target hikes, gene therapy logistics wins and a 29-year dividend growth streak supporting the uptrend.
See More Headlines

CAH Stock Analysis - Frequently Asked Questions

Cardinal Health's stock was trading at $205.62 at the start of the year. Since then, CAH shares have increased by 14.1% and is now trading at $234.5360.

Cardinal Health, Inc. (NYSE:CAH) posted its earnings results on Tuesday, August, 11th. The company reported $2.91 EPS for the quarter, beating analysts' consensus estimates of $2.42 by $0.49. The firm's quarterly revenue was up 5.8% compared to the same quarter last year.
Read the conference call transcript
.

The following companies are subsidiaries of Cardinal Health: Mscripts, Mirixa Corporation, Patient Recovery Business of Medtronic, TelePharm, RainTree Oncology Services, NaviHealth, Outcomes Incorporated, and others.

Top institutional investors of Cardinal Health include California State Teachers Retirement System (36.63%), BlackRock Inc. (11.31%), Wellington Management Group LLP (6.39%) and Bank of America Corp DE (1.25%). Insiders that own company stock include Jason M Hollar, Deborah Weitzman, Aaron E Alt, Jessica L Mayer, Stephen M Mason, Ola M Snow, Michelle D Greene and Mary C Scherer.
View institutional ownership trends
.

Shares of CAH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cardinal Health investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), ExxonMobil (XOM), Broadcom (AVGO), AbbVie (ABBV) and Chevron (CVX).

Company Calendar

Record date for 7/15 Dividend
7/01/2026
Ex-Dividend for 7/15 Dividend
7/01/2026
Dividend Payable
7/15/2026
Last Earnings
8/11/2026
Today
9/12/2026
Morgan Stanley 24th Annual Global Healthcare Conference
9/14/2026
2026 Global Healthcare Conference
9/15/2026
Record date for 10/15 Dividend
10/01/2026
Ex-Dividend for 10/15 Dividend
10/01/2026
Dividend Payable
10/15/2026
Next Earnings (Estimated)
10/29/2026
Fiscal Year End
6/30/2027

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
Healthcare Providers & Services
Sub-Industry
Healthcare Distributors
Current Symbol
NYSE:CAH
CIK
721371
Employees
63,900
Year Founded
1971

Price Target and Rating

High Price Target
$292.00
Low Price Target
$208.00
Potential Upside/Downside
+13.7%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.84
Research Coverage
19 Analysts

Profitability

EPS (Trailing Twelve Months)
$7.23
Trailing P/E Ratio
32.44
Forward P/E Ratio
18.69
P/E Growth
1.42
Net Income
$1.71 billion
Net Margins
0.67%
Pretax Margin
0.86%
Return on Equity
-98.53%
Return on Assets
4.69%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.88
Quick Ratio
0.49

Sales & Book Value

Annual Sales
$254.25 billion
Price / Sales
0.21
Cash Flow
$15.37 per share
Price / Cash Flow
15.26
Book Value
($11.63) per share
Price / Book
-20.17

Miscellaneous

Outstanding Shares
232,580,000
Free Float
232,297,000
Market Cap
$54.55 billion
Optionable
Optionable
Beta
0.51

Social Links

The 7 Hottest IPO Stories of 2026 Cover

MarketBeat just released its list of the 7 hottest IPOs expected to hit Wall Street in 2026. See which companies are preparing to go public and why investors are watching closely.

Get This Free Report

This page (NYSE:CAH) was last updated on 9/12/2026 by MarketBeat.com Staff.
From Our Partners